Meningeal Inflammation on 7T MRI as a Tool for Measuring and Predicting Ocrelizumab Response in Multiple Sclerosis

NCT03396822 · clinicaltrials.gov ↗

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Gadoteridol

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]